GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Parexel International Corporation (PRXL) [hlAlert]

Rating:
Perform PRXL
up 151.57 %

Parexel International Corporation (PRXL) rated Perform with price target $22 by Oppenheimer

Posted on: Monday,  Oct 25, 2010  8:25 AM ET by Oppenheimer

Oppenheimer rated Perform Parexel International Corporation (NASDAQ: PRXL) on 10/25/2010. Previously Oppenheimer rated Outperform Parexel International Corporation (NASDAQ: PRXL) on 02/01/2008.,
when the stock price was $27.52. Since then, Parexel International Corporation has gained 151.57% as of 01/25/2016's recent price of $69.22.
If you would have followed the previous Oppenheimer's recommendation on PRXL, you would have gained 151.57% of your investment in 2915 days.

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/25/2010 8:25 AM Buy
None
21.38 22.00
as of 12/31/2010
1 Week down  -5.61 %
1 Month up  18.35 %
3 Months down  -9.94 %
1 YTD up  47.73 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/28/2010 8:25 AM Buy
None
25.39 29.00
2/1/2008 8:25 AM Buy
None
27.52 35.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy